The global brain computer interface (BCI) market, considering invasive BCIs, the total addressable market (TAM) was estimated at USD 168.27 billion in 2025 according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 1.52% from 2026 to 2033 and the global brain computer interface (BCI) market, considering non- invasive BCIs the serviceable obtainable market (SOM) was estimated at USD 397.59 million in 2025 and is projected to grow at a CAGR of 8.73% from 2026 to 2033. Brain computer interface (BCI) is a revolutionary technology that facilitates direct contact between peripheral electronic devices calibrating the movement and a functional brain in physically challenged people. This system records the brain signal from the sensors that are placed over the scalp or devices implanted in the brain.
It also stated Artificial intelligence (AI) is emerging as a key opportunity in the brain computer interface (BCI) market, enabling faster and more accurate neural signal decoding and more intuitive, responsive device control. Market growth is further supported by ongoing advancements in medical sensors and computational biology, which are improving signal acquisition, processing efficiency, and system reliability. In addition, rising R&D investments focused on developing novel treatment solutions for chronic and complex conditions such as cerebrovascular diseases, sleep disorders, neurological disorders, and traumatic or fatal brain injuries are expected to significantly contribute to overall market expansion.
Furthermore, technological advancements, along with increasing initiatives by key industry players, are significantly contributing to market growth. Rising demand for immersive gaming experiences is driving the development of advanced technologies such as augmented brain computer interfaces, expanding both commercial and consumer applications. In addition, growing strategic initiatives by companies to raise awareness and accelerate adoption through industry events, demonstrations, and partnerships are strengthening market visibility. For instance, in December 2025, China showcased its latest advances in brain computer interface technology at the 2025 Shenzhen Brain-Computer Interface & Human-Computer Interaction Expo, unveiling a new AI innovation alliance and an USD 1.65 billion (¥11.6 billion) brain science industry fund to support BCI and related neurological research and commercialization effort. Such government-backed funding programs and policy-driven innovation ecosystems are expected to accelerate technology development, clinical translation, and large-scale adoption, thereby supporting sustained market expansion.
Request a free sample copy or view report summary: Brain Computer Interface Market Report
In the brain computer interface (BCI) market, the total addressable market (TAM) for invasive BCIs is expected to grow at a CAGR of 1.52% from 2026 to 2033, driven by strong clinical evidence supporting their effectiveness in restoring motor function and communication in patients with conditions such as amyotrophic lateral sclerosis (ALS), spinal cord injuries, and stroke. In contrast, the serviceable obtainable market (SOM) for non-invasive BCIs is projected to grow at a faster CAGR of 8.73% from 2026 to 2033, supported by increasing adoption across home automation, virtual gaming, and military communication applications, which broadens use cases beyond clinical settings and accelerates overall market growth.
On the basis of application, healthcare was the largest revenue-generating segment in 2025. Wide application of BCI technology in the treatment of sleeping disorders, Alzheimer’s, and Parkinson’s is a vital factor contributing to the segment growth.
The entertainment & gaming segment is expected to register the fastest CAGR over the forecast period owing to the increasing investment and rising awareness about the technology
On basis of end use medical segment dominated the market owing to its application in assisting disabled patients. BCI assists patients suffering from diseases such as paralysis, epilepsy, parkinsonism, and Alzheimer’s
Asia Pacific is expected to exhibit the fastest CAGR over the forecast period. Significant untapped opportunities, increasing healthcare expenditure, and growing awareness amongst patients expected to drive the regional market growth in the coming years.
The BCI is an emerging technology that is currently at a nascent stage; however, the increasing interest among researchers in collaboration with the government is expected to fuel market growth.
Grand View Research has segmented the global brain computer interface market report based on product, application, end-use, and region:
Brain-Computer Interface (BCI) Product Outlook (Revenue, USD Million, 2021 - 2033)
Invasive Brain-Computer Interface (BCI) [Total Addressable Market (TAM)]
Non Invasive Brain-Computer Interface (BCI) [Serviceable Obtainable Market (SOM)]
Invasive Brain-Computer Interface (BCI) Application Outlook :(Revenue in USD Million; 2021 - 2033) [Total Addressable Market (TAM)]
MND/ALS
Stroke
Spinal Cord Injury
Multiple Sclerosis Patients
Cerebral Palsy
Amputation
Epilepsy
Depression
Parkinson's Disease
Non Invasive BCI Application Outlook (Revenue in USD Million; 2021 - 2033) [Serviceable Obtainable Market (SOM)]
Healthcare
Disabilities Restoration
Brain Function Repair
Smart Home Control
Communication and control
Entertainment & Gaming
Non Invasive BCI End Use Outlook (Revenue in USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
Medical
Education & Research
Others (Consumer & Wellness, etc.)
Non Invasive BCI Regional Outlook (Revenue, USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Brain Computer Interface Market
Medtronic
g.tec medical engineering GmbH
Natus Medical Incorporated
Compumedics Neuroscan
Brain Products GmbH
Integra LifeSciences Corporation
Advanced Brain Monitoring, Inc.
EMOTIV
NeuroSky
ANT Neuro
NIRx Medical Technologies, LLC
Ripple Neuro.
Neuroelectrics
OpenBCI
COGNIONICS, INC. (CGX)
Blackrock Neurotech
Synchron
Neurable
"The quality of research they have done for us has been excellent..."